Mitra Adiperkasa (MAPI IJ) Buy: Nascent recovery

Research evidence excerpt

Mitra Adiperkasa (MAPI IJ) Buy: Nascent recovery

l and professional investor (as defined by Securities and Future Ordinance (Chapter 571)) customers only; it is not intended for and should not be distributed to retail customers in

Hong Kong, unless permitted otherwise. All enquiries by recipients in Hong Kong must be directed to your HSBC contact in Hong Kong. The Hongkong and Shanghai Banking Corporation

Limited is regulated by the Hong Kong Monetary Authority.

If it is received by a customer of an affiliate of HSBC, its provision to the recipient is subject to the terms of business in place between the recipient and such affiliate. This document is not and

should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. HSBC has based this document on information obtained from sources it

believes to be reliable but which it has not independently verified; HSBC makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or

completeness. Expressions of opinion are those of the Research Division of HSBC only and are subject to change without notice. From time to time research analysts conduct site visits of

covered issuers. HSBC policies prohibit research analysts from accepting payment or reimbursement for travel expenses from the issuer for such visits. HSBC and its affiliates and/or their

officers, directors and employees may have positions in any securities mentioned in this document (or in any related investment) and may from time to time add to or dispose of any such

securities (or investment). HSBC and its affiliates may act as market maker or have assumed an underwriting commitment in the securities of companies discussed in this document (or in related